Cost-Effectiveness Analysis of Topical Calcipotriol versus Short- Contact Dithranol

Darren M. Ashcroft; A. Li Wan Po; Hywel C Williams; Christopher Em Griffiths

doi:10.2165/00019053-200018050-00006

Related publications

Article2011

Individualized Cost-Effectiveness Analysis

John P A Ioannidis, Alan M. Garber

Article2018

PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN

Shunya Ikeda, Masatoshi Kudo, Namiki Izumi, Satoshi Kaneko, Masahiro Kobayashi, Mie Azuma, Ronda Copher, Suchin Virabhak, David Mitchell, Genevieve Meier, Mika Ishii

Article2015

Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective

Ruben L.J. Osnabrugge, Elizabeth A. Magnuson, Patrick W. Serruys, Carlos M. Campos, Kaijun Wang, David van Klaveren, Vasim Farooq, Mouin Abdallah, Haiyan Li, Katherine A. Vilain, Ewout W. Steyerberg, Marie‐Claude Morice, Keith D. Dawkins, Friedrich W. Mohr, A. Pieter Kappetein, David J. Cohen

Heart

Article2014

Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis

Andrea C. Tricco, Huda Ashoor, Jesmin Antony, Joseph Beyene, A. A. Veroniki, Wanrudee Isaranuwatchai, A. Harrington, Charlotte Wilson, Sophia Tsouros, Charlene Soobiah, Catherine Yu, Brian Hutton, Jeffrey S. Hoch, Brenda R. Hemmelgarn, David Moher, Sumit R. Majumdar, Sharon E. Straus

Article1993

Cost-Effectiveness of Antihypertensive Treatment

Magnus Johannesson, John Wikstrand, Bengt Jønsson, G. Berglund, Jaakko Tuomilehto

PharmacoEconomics